In Vitro and In Vivo Anti-Breast Cancer Activities of Some Synthesized Pyrazolinyl-estran-17-one Candidates

Molecules. 2018 Jun 28;23(7):1572. doi: 10.3390/molecules23071572.

Abstract

A series of estrone derivatives, 24, were synthesized from the corresponding arylidine estrone, 2a,b, as starting materials, which were prepared by condensation of estrone (3-hydroxy-estran-17-one, 1) with 4-bromobenzaldehyde and thiophene-2-aldehyde. Treating of 2a,b with hydrazine derivatives in acetic acid or propionic acid afforded pyrazoline derivatives, 3af and 4af, respectively. Furthermore, results proved the superiority of thienyl derivatives over 4-bromophenol derivatives in terms of cytotoxic effects on MCF-7 cancer cells. In vivo xenograft breast cancer animal model experiments revealed that the synthesized derivatives can be used for decreasing tumor volume, while the most potent derivative (4f) decreased the development of tumor volume by about 87.0% after 12 days.

Keywords: anti-breast cancer; biological activities; cytotoxicty; estrone; steroidal scaffold.

MeSH terms

  • Animals
  • Antineoplastic Agents / chemistry
  • Antineoplastic Agents / pharmacology*
  • Antineoplastic Agents / therapeutic use
  • Breast Neoplasms / drug therapy*
  • Breast Neoplasms / metabolism
  • Estrone / chemistry
  • Female
  • Humans
  • MCF-7 Cells
  • Pyrazoles / chemistry
  • Xenograft Model Antitumor Assays

Substances

  • Antineoplastic Agents
  • Pyrazoles
  • Estrone